Apogee Therapeutics, Inc.
- APGE
- NASDAQ
- Biotechnology
- Immunology/Inflammation Biologics
- Atopic Dermatitis/COPD Antibody Therapies
$135.07
Quote Sep 4, 2026, 08:00 PM UTC
+0.66%over the last month
Max drawdown −0.3%From 1-month high −0.0%3 months +60.4%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$10.19B
Approximate share count
Next earnings
Nov 9
Expected, not confirmed
Analyst target
$130.92
−3.1% from here
Floor
$133.96
0.8% below price
Where the price sits
14 analysts
Analyst range, low to high
$89.00$140.00
- Price $135.07
- Resistance $135.12
- Consensus $130.92
The price is just above its floor and right under resistance. Analysts' average target sits about 3% lower.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about APGEPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
261